154 related articles for article (PubMed ID: 1090363)
1. In vitro metabolism and microsome-mediated mutagenicity of dialkylnitrosamines in rat, hamster, and mouse tissues.
Bartsch H; Malaveille C; Montesano R
Cancer Res; 1975 Mar; 35(3):644-51. PubMed ID: 1090363
[TBL] [Abstract][Full Text] [Related]
2. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting metabolism and mutagenicity of dimethylnitrosamine and diethylnitrosamine.
Frantz CN; Malling HV
Cancer Res; 1975 Sep; 35(9):2307-14. PubMed ID: 1097107
[TBL] [Abstract][Full Text] [Related]
4. Microsome-mediated mutagenesis in V79 Chinese hamster cells by various nitrosamines.
Kuroki T; Drevon C; Montesano R
Cancer Res; 1977 Apr; 37(4):1044-50. PubMed ID: 321116
[TBL] [Abstract][Full Text] [Related]
5. Species specificity in the metabolism of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine to mutagens by isolated rat and hamster hepatocytes.
Mangino MM; Hollenberg PF; Scarpelli DG
Cancer Res; 1987 Sep; 47(18):4776-81. PubMed ID: 3113724
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of beta-oxidized N,N,-di-n-propylnitrosamine derivatives in S. typhimurium mediated by rat and hamster tissues.
Camus A; Bertram B; Krüger FW; Malaveille C; Bartsch H
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):293-302. PubMed ID: 136104
[TBL] [Abstract][Full Text] [Related]
7. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
Prival MJ; Mitchell VD
Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
[TBL] [Abstract][Full Text] [Related]
8. Influence of mixed-function oxidase inducers on the in vitro metabolism of N'-nitrosonornicotine by rat and hamster liver microsomes.
McCoy GD; Chen CB; Hecht SS
Drug Metab Dispos; 1981; 9(2):168-9. PubMed ID: 6113118
[No Abstract] [Full Text] [Related]
9. Participation of phenobarbital-inducible cytochrome P450 in the mutagenic activation of N-nitrosopropylamines by liver and lung 9000 g fractions from five animal species and man.
Mori Y; Konishi Y
IARC Sci Publ; 1991; (105):398-403. PubMed ID: 1855888
[TBL] [Abstract][Full Text] [Related]
10. Sex-dependent induction of hepatic enzymes for mutagenic activation of a tryptophan pyrolysate component, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]-indole, by feeding in mice.
Degawa M; Kojima M; Hishinuma T; Hashimoto Y
Cancer Res; 1985 Jan; 45(1):96-102. PubMed ID: 3880668
[TBL] [Abstract][Full Text] [Related]
11. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
[TBL] [Abstract][Full Text] [Related]
12. Alkylation of DNA and tissue specificity in nitrosamine carcinogenesis.
Montesano R
J Supramol Struct Cell Biochem; 1981; 17(3):259-73. PubMed ID: 7328674
[TBL] [Abstract][Full Text] [Related]
13. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
Hales BF
Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
[TBL] [Abstract][Full Text] [Related]
14. Carcinogenicity and mutagenicity of N-nitroso compounds.
Lijinsky W
Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
[TBL] [Abstract][Full Text] [Related]
15. [Study of promutagen biotransformation in the Ames test. III. The role of conjugation with glucuronic acid and sulfate in the modification of mutagenic effect of nitrosomorpholine, diethylnitrosamine and cyclophosphamide].
Loknitskaia NN; Rotenberg IuS; Fonshteĭn LM; Shuliakovskaia TS
Genetika; 1986 Sep; 22(9):2259-64. PubMed ID: 3533722
[TBL] [Abstract][Full Text] [Related]
16. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
Ress NB;
Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
[TBL] [Abstract][Full Text] [Related]
17. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
Hecker LI; Saavedra JE; Farrelly JG; Andrews AW
Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365
[TBL] [Abstract][Full Text] [Related]
18. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.
Lijinsky W; Andrews AW
Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenicity of diallylnitrosamine following intragastric administration to Syrian hamsters.
Grandjean CJ; Althoff J; Pour PM
J Natl Cancer Inst; 1985 May; 74(5):1043-6. PubMed ID: 3858573
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and mutagenicity of N-nitroso-2-methoxy-2,6-dimethylmorpholine in hamsters.
Gingell R; Brunk G; Nagel D; Wallcave L; Walker B; Pour P
J Natl Cancer Inst; 1980 Jan; 64(1):157-61. PubMed ID: 6928040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
